TrialPediatric blood & cancer2012

Initial testing (stage 1) by the pediatric preclinical testing program of RO4929097, a γ-secretase inhibitor targeting notch signaling.

E Anders Kolb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.